Do analysts rate CCM or BRTX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Concord Medical Services 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has preferable valuation & earnings, CCM or BRTX?

Concord Medical Services has higher revenue and earnings than Biorestorative Therapies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Concord Medical Services $65.85M 0.29 -$13.27M N/A N/A Biorestorative Therapies $360K 26.12 -$14.24M -$1.07 N/A

Do analysts prefer MRAI or BRTX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Marpai 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend BMGL or BRTX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger valuation & earnings, BMGL or BRTX?

Basel Medical Group has higher revenue and earnings than Biorestorative Therapies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Basel Medical Group $11.32M 0.91 -$9.50M N/A N/A Biorestorative Therapies $360K 26.12 -$14.24M -$1.07 N/A

Do analysts recommend ACON or BRTX?

Aclarion presently has a consensus price target of $7.50, suggesting a potential upside of 138.32%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Biorestorative Therapies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aclarion 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate ADVB or BRTX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Advanced Biomed 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Biorestorative Therapies 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Biorestorative Therapies (BRTX) Competitors

$0.37 +0.02 (+4.68%)

As of 10:21 AM Eastern

Compare

BRTX vs. CCM, MRAI, BMGL, ACON, and ADVB

Should you buy Biorestorative Therapies stock or one of its competitors? MarketBeat compares Biorestorative Therapies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Biorestorative Therapies include Concord Medical Services (CCM), Marpai (MRAI), Basel Medical Group (BMGL), Aclarion (ACON), and Advanced Biomed (ADVB). These companies are all part of the "healthcare" industry.

How does Biorestorative Therapies compare to Concord Medical Services?

Concord Medical Services (NYSE:CCM) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, valuation, profitability, earnings, institutional ownership, dividends and media sentiment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Concord Medical Services	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Concord Medical Services had 1 more articles in the media than Biorestorative Therapies. MarketBeat recorded 3 mentions for Concord Medical Services and 2 mentions for Biorestorative Therapies. Biorestorative Therapies' average media sentiment score of 0.44 beat Concord Medical Services' score of 0.22 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company	Overall Sentiment
Concord Medical Services	Neutral
Biorestorative Therapies	Neutral

69.4% of Biorestorative Therapies shares are owned by institutional investors. 46.5% of Concord Medical Services shares are owned by company insiders. Comparatively, 13.6% of Biorestorative Therapies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Concord Medical Services has a beta of -0.99, meaning that its stock price is 199% less volatile than the broader market. Comparatively, Biorestorative Therapies has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

Concord Medical Services has higher revenue and earnings than Biorestorative Therapies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Concord Medical Services	$65.85M	0.29	-$13.27M	N/A	N/A
Biorestorative Therapies	$360K	26.12	-$14.24M	-$1.07	N/A

Concord Medical Services has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,088.27%. Concord Medical Services' return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Concord Medical Services	N/A	N/A	N/A
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%

Summary

Concord Medical Services beats Biorestorative Therapies on 7 of the 11 factors compared between the two stocks.

How does Biorestorative Therapies compare to Marpai?

Marpai (NASDAQ:MRAI) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, earnings, valuation, institutional ownership, dividends, media sentiment, analyst recommendations and risk.

In the previous week, Biorestorative Therapies had 2 more articles in the media than Marpai. MarketBeat recorded 2 mentions for Biorestorative Therapies and 0 mentions for Marpai. Biorestorative Therapies' average media sentiment score of 0.44 beat Marpai's score of 0.00 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company	Overall Sentiment
Marpai	Neutral
Biorestorative Therapies	Neutral

49.8% of Marpai shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 46.1% of Marpai shares are held by insiders. Comparatively, 13.6% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Marpai has a net margin of -85.70% compared to Biorestorative Therapies' net margin of -3,088.27%. Marpai's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Marpai	-85.70%	N/A	-100.23%
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Marpai	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Biorestorative Therapies has lower revenue, but higher earnings than Marpai. Marpai is trading at a lower price-to-earnings ratio than Biorestorative Therapies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Marpai	$34.87M	0.44	-$28.75M	-$0.87	N/A
Biorestorative Therapies	$360K	26.12	-$14.24M	-$1.07	N/A

Marpai has a beta of 4.94, suggesting that its share price is 394% more volatile than the broader market. Comparatively, Biorestorative Therapies has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

Summary

Marpai beats Biorestorative Therapies on 8 of the 14 factors compared between the two stocks.

How does Biorestorative Therapies compare to Basel Medical Group?

Basel Medical Group (NASDAQ:BMGL) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitability, media sentiment and earnings.

Basel Medical Group has higher revenue and earnings than Biorestorative Therapies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$11.32M	0.91	-$9.50M	N/A	N/A
Biorestorative Therapies	$360K	26.12	-$14.24M	-$1.07	N/A

In the previous week, Basel Medical Group had 6 more articles in the media than Biorestorative Therapies. MarketBeat recorded 8 mentions for Basel Medical Group and 2 mentions for Biorestorative Therapies. Biorestorative Therapies' average media sentiment score of 0.44 beat Basel Medical Group's score of 0.23 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company	Overall Sentiment
Basel Medical Group	Neutral
Biorestorative Therapies	Neutral

69.4% of Biorestorative Therapies shares are owned by institutional investors. 13.6% of Biorestorative Therapies shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Basel Medical Group has a beta of 0.19, suggesting that its share price is 81% less volatile than the broader market. Comparatively, Biorestorative Therapies has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market.

Basel Medical Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,088.27%. Basel Medical Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%

Summary

Basel Medical Group beats Biorestorative Therapies on 6 of the 11 factors compared between the two stocks.

How does Biorestorative Therapies compare to Aclarion?

Aclarion (NASDAQ:ACON) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk.

In the previous week, Aclarion had 2 more articles in the media than Biorestorative Therapies. MarketBeat recorded 4 mentions for Aclarion and 2 mentions for Biorestorative Therapies. Biorestorative Therapies' average media sentiment score of 0.44 beat Aclarion's score of 0.31 indicating that Biorestorative Therapies is being referred to more favorably in the news media.

Company	Overall Sentiment
Aclarion	Neutral
Biorestorative Therapies	Neutral

Aclarion has higher earnings, but lower revenue than Biorestorative Therapies. Aclarion is trading at a lower price-to-earnings ratio than Biorestorative Therapies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aclarion	$77.88K	99.49	-$7.23M	-$9.03	N/A
Biorestorative Therapies	$360K	26.12	-$14.24M	-$1.07	N/A

Aclarion has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, Biorestorative Therapies has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market.

7.5% of Aclarion shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 0.0% of Aclarion shares are held by insiders. Comparatively, 13.6% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Biorestorative Therapies has a net margin of -3,088.27% compared to Aclarion's net margin of -10,320.51%. Aclarion's return on equity of -54.41% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aclarion	-10,320.51%	-54.41%	-51.71%
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%

Aclarion presently has a consensus price target of $7.50, suggesting a potential upside of 138.32%. Given Aclarion's stronger consensus rating and higher possible upside, analysts clearly believe Aclarion is more favorable than Biorestorative Therapies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aclarion	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Aclarion beats Biorestorative Therapies on 9 of the 16 factors compared between the two stocks.

How does Biorestorative Therapies compare to Advanced Biomed?

Advanced Biomed (NASDAQ:ADVB) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, dividends, media sentiment, risk, analyst recommendations, valuation and institutional ownership.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomed	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Biorestorative Therapies	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Advanced Biomed has a beta of 0.68, indicating that its share price is 32% less volatile than the broader market. Comparatively, Biorestorative Therapies has a beta of 0.66, indicating that its share price is 34% less volatile than the broader market.

69.4% of Biorestorative Therapies shares are held by institutional investors. 27.0% of Advanced Biomed shares are held by company insiders. Comparatively, 13.6% of Biorestorative Therapies shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Advanced Biomed has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,088.27%. Advanced Biomed's return on equity of 87.74% beat Biorestorative Therapies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Advanced Biomed	N/A	87.74%	64.49%
Biorestorative Therapies	-3,088.27%	-508.42%	-230.94%

In the previous week, Biorestorative Therapies had 1 more articles in the media than Advanced Biomed. MarketBeat recorded 2 mentions for Biorestorative Therapies and 1 mentions for Advanced Biomed. Advanced Biomed's average media sentiment score of 1.89 beat Biorestorative Therapies' score of 0.44 indicating that Advanced Biomed is being referred to more favorably in the media.

Company	Overall Sentiment
Advanced Biomed	Very Positive
Biorestorative Therapies	Neutral

Advanced Biomed has higher earnings, but lower revenue than Biorestorative Therapies. Biorestorative Therapies is trading at a lower price-to-earnings ratio than Advanced Biomed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomed	N/A	N/A	-$3.26M	$4.82	0.94
Biorestorative Therapies	$360K	26.12	-$14.24M	-$1.07	N/A

Summary

Advanced Biomed beats Biorestorative Therapies on 9 of the 12 factors compared between the two stocks.

Get Biorestorative Therapies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BRTX vs. The Competition

Export

Metric	Biorestorative Therapies	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$9.25M	$3.39B	$6.49B	$12.31B
Dividend Yield	N/A	2.25%	2.67%	5.66%
P/E Ratio	-0.34	20.05	24.05	24.76
Price / Sales	26.12	325.48	542.61	168.32
Price / Cash	N/A	53.61	27.48	37.92
Price / Book	9.23	8.16	10.69	6.90
Net Income	-$14.24M	$23.89M	$3.57B	$337.45M
7 Day Performance	1.93%	3.66%	1.56%	2.84%
1 Month Performance	91.99%	1.69%	2.49%	4.78%
1 Year Performance	-78.04%	46.95%	26.51%	33.08%

Biorestorative Therapies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BRTX Biorestorative Therapies	0.5582 of 5 stars	$0.37 +4.7%	N/A	-79.0%	$9.25M	$360K	N/A	7
CCM Concord Medical Services	0.5114 of 5 stars	$4.63 -1.7%	N/A	-32.8%	$20.09M	$65.85M	N/A	970	Gap Up
MRAI Marpai	N/A	$0.52 -8.8%	N/A	-59.0%	$13.30M	$34.87M	N/A	150	Gap Down
BMGL Basel Medical Group	0.7243 of 5 stars	$0.59 -8.0%	N/A	-83.0%	$11.03M	$8.90M	N/A	36	Gap Down
ACON Aclarion	3.6532 of 5 stars	$3.16 -3.1%	$7.50 +137.3%	-58.1%	$7.77M	$80K	N/A	7

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:BRTX) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Biorestorative Therapies (BRTX) Competitors

BRTX vs. CCM, MRAI, BMGL, ACON, and ADVB

How does Biorestorative Therapies compare to Concord Medical Services?

Summary

How does Biorestorative Therapies compare to Marpai?

Summary

How does Biorestorative Therapies compare to Basel Medical Group?

Summary

How does Biorestorative Therapies compare to Aclarion?

Summary

How does Biorestorative Therapies compare to Advanced Biomed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRTX vs. The Competition

Biorestorative Therapies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Biorestorative Therapies (BRTX) Competitors

BRTX vs. CCM, MRAI, BMGL, ACON, and ADVB

How does Biorestorative Therapies compare to Concord Medical Services?

Do analysts rate CCM or BRTX?

Does the media prefer CCM or BRTX?

Do insiders and institutionals hold more shares of CCM or BRTX?

Which has more risk and volatility, CCM or BRTX?

Which has preferable valuation & earnings, CCM or BRTX?

Is CCM or BRTX more profitable?

Summary

How does Biorestorative Therapies compare to Marpai?

Does the media prefer MRAI or BRTX?

Do institutionals and insiders believe in MRAI or BRTX?

Is MRAI or BRTX more profitable?

Do analysts prefer MRAI or BRTX?

Which has preferable earnings and valuation, MRAI or BRTX?

Which has more risk and volatility, MRAI or BRTX?

Summary

How does Biorestorative Therapies compare to Basel Medical Group?

Which has stronger valuation & earnings, BMGL or BRTX?

Does the media refer more to BMGL or BRTX?

Do institutionals & insiders believe in BMGL or BRTX?

Do analysts recommend BMGL or BRTX?

Which has more risk and volatility, BMGL or BRTX?

Is BMGL or BRTX more profitable?

Summary

How does Biorestorative Therapies compare to Aclarion?

Does the media prefer ACON or BRTX?

Which has higher earnings and valuation, ACON or BRTX?

Which has more volatility & risk, ACON or BRTX?

Do institutionals & insiders hold more shares of ACON or BRTX?

Is ACON or BRTX more profitable?

Do analysts recommend ACON or BRTX?

Summary

How does Biorestorative Therapies compare to Advanced Biomed?

Do analysts rate ADVB or BRTX?

Which has more volatility & risk, ADVB or BRTX?

Do insiders & institutionals have more ownership in ADVB or BRTX?

Is ADVB or BRTX more profitable?

Does the media refer more to ADVB or BRTX?

Which has preferable earnings & valuation, ADVB or BRTX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BRTX vs. The Competition

Biorestorative Therapies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools